Sanofi Gets Reprieve In Amphastar's Lovenox FCA Suit

By Daniel Wilson (October 1, 2012, 6:35 PM EDT) -- A California federal judge on Friday dismissed a False Claims Act suit accusing Sanofi-Aventis SA of making false patent claims for anti-clotting drug Lovenox to unfairly keep generic competition off the market, but the ruling gave plaintiff Amphastar Pharmaceuticals Inc. leave to amend its complaint....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!